栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/03/01 | 2,555 | 2,560 | 2,457.5 | 2,477.5 | -112.5 | -4.3% | 218,000 |
2018/02/28 | 2,620 | 2,650 | 2,590 | 2,590 | -50 | -1.9% | 159,200 |
2018/02/27 | 2,575 | 2,650 | 2,565 | 2,640 | +75 | +2.9% | 166,800 |
2018/02/26 | 2,610 | 2,610 | 2,555 | 2,565 | +5 | +0.2% | 96,800 |
2018/02/23 | 2,550 | 2,570 | 2,540 | 2,560 | -5 | -0.2% | 58,000 |
2018/02/22 | 2,500 | 2,565 | 2,500 | 2,565 | +35 | +1.4% | 113,000 |
2018/02/21 | 2,460 | 2,550 | 2,430 | 2,530 | +52.5 | +2.1% | 140,000 |
2018/02/20 | 2,475 | 2,500 | 2,442.5 | 2,477.5 | -10 | -0.4% | 114,600 |
2018/02/19 | 2,450 | 2,490 | 2,437.5 | 2,487.5 | +70 | +2.9% | 118,600 |
2018/02/16 | 2,402.5 | 2,437.5 | 2,375 | 2,417.5 | +97.5 | +4.2% | 263,200 |
2018/02/15 | 2,285 | 2,330 | 2,267.5 | 2,320 | +37.5 | +1.6% | 126,200 |
2018/02/14 | 2,307.5 | 2,322.5 | 2,257.5 | 2,282.5 | -30 | -1.3% | 167,200 |
2018/02/13 | 2,360 | 2,367.5 | 2,297.5 | 2,312.5 | -60 | -2.5% | 253,800 |
2018/02/09 | 2,420 | 2,437.5 | 2,352.5 | 2,372.5 | -132.5 | -5.3% | 199,000 |
2018/02/08 | 2,450 | 2,540 | 2,450 | 2,505 | +85 | +3.5% | 194,400 |
2018/02/07 | 2,515 | 2,525 | 2,420 | 2,420 | +37.5 | +1.6% | 234,000 |
2018/02/06 | 2,530 | 2,530 | 2,345 | 2,382.5 | -197.5 | -7.7% | 290,400 |
2018/02/05 | 2,575 | 2,605 | 2,555 | 2,580 | -15 | -0.6% | 238,600 |
2018/02/02 | 2,540 | 2,610 | 2,540 | 2,595 | +85 | +3.4% | 275,800 |
2018/02/01 | 2,440 | 2,520 | 2,440 | 2,510 | +85 | +3.5% | 228,800 |
2018/01/31 | 2,442.5 | 2,492.5 | 2,422.5 | 2,425 | +5 | +0.2% | 273,000 |
2018/01/30 | 2,427.5 | 2,460 | 2,400 | 2,420 | -17.5 | -0.7% | 309,800 |
2018/01/29 | 2,450 | 2,590 | 2,402.5 | 2,437.5 | -25 | -1% | 1,157,800 |
2018/01/26 | 2,495 | 2,505 | 2,447.5 | 2,462.5 | -57.5 | -2.3% | 352,000 |
2018/01/25 | 2,545 | 2,550 | 2,505 | 2,520 | -20 | -0.8% | 136,400 |
2018/01/24 | 2,595 | 2,600 | 2,530 | 2,540 | -35 | -1.4% | 239,200 |
2018/01/23 | 2,600 | 2,620 | 2,575 | 2,575 | -10 | -0.4% | 167,200 |
2018/01/22 | 2,615 | 2,615 | 2,565 | 2,585 | -30 | -1.1% | 126,400 |
2018/01/19 | 2,570 | 2,625 | 2,565 | 2,615 | +60 | +2.3% | 184,000 |
2018/01/18 | 2,570 | 2,580 | 2,545 | 2,555 | +5 | +0.2% | 151,000 |
2018/01/17 | 2,540 | 2,565 | 2,540 | 2,550 | -5 | -0.2% | 96,200 |
2018/01/16 | 2,585 | 2,600 | 2,545 | 2,555 | -15 | -0.6% | 176,600 |
2018/01/15 | 2,580 | 2,590 | 2,565 | 2,570 | ±0 | ±0% | 121,400 |
2018/01/12 | 2,565 | 2,605 | 2,550 | 2,570 | -20 | -0.8% | 418,000 |
2018/01/11 | 2,660 | 2,675 | 2,580 | 2,590 | -105 | -3.9% | 262,000 |
2018/01/10 | 2,750 | 2,750 | 2,685 | 2,695 | -65 | -2.4% | 154,800 |
2018/01/09 | 2,745 | 2,805 | 2,740 | 2,760 | +15 | +0.5% | 135,400 |
2018/01/05 | 2,750 | 2,760 | 2,715 | 2,745 | +5 | +0.2% | 91,800 |
2018/01/04 | 2,725 | 2,755 | 2,725 | 2,740 | +40 | +1.5% | 85,600 |
2017/12/29 | 2,715 | 2,725 | 2,690 | 2,700 | -5 | -0.2% | 64,400 |
2017/12/28 | 2,740 | 2,770 | 2,700 | 2,705 | -55 | -2% | 80,800 |
2017/12/27 | 2,690 | 2,760 | 2,685 | 2,760 | +60 | +2.2% | 100,800 |
2017/12/26 | 2,715 | 2,760 | 2,695 | 2,700 | -15 | -0.6% | 95,200 |
2017/12/25 | 2,655 | 2,720 | 2,635 | 2,715 | +65 | +2.5% | 122,000 |
2017/12/22 | 2,620 | 2,655 | 2,615 | 2,650 | +10 | +0.4% | 82,800 |
2017/12/21 | 2,615 | 2,645 | 2,605 | 2,640 | +20 | +0.8% | 82,600 |
2017/12/20 | 2,590 | 2,625 | 2,585 | 2,620 | +20 | +0.8% | 96,600 |
2017/12/19 | 2,620 | 2,640 | 2,600 | 2,600 | -50 | -1.9% | 94,800 |
2017/12/18 | 2,635 | 2,675 | 2,625 | 2,650 | +35 | +1.3% | 217,000 |
2017/12/15 | 2,620 | 2,645 | 2,605 | 2,615 | -15 | -0.6% | 127,200 |
1751~
1800
件表示中 / 6946件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 222,200円 | +0.4% | -8.4% | 2.39% | 28.52倍 | 1.61倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
持田薬 | 309,000円 | +3.0% | +27.5% | 2.59% | 19.56倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 148,600円 | +8.8% | +99.9% | 3.50% | 9.49倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ネクセラファーマ | 93,400円 | +22.8% | - | 0.00% | 76.31倍 | 1.23倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
あすかHD | 229,600円 | +0.3% | +2.7% | 2.18% | 13.02倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム